The pharmaceutical industry was able to further increase its sales in the last quarter. The biggest players in the sector are relying on acquisitions and innovations – including the increased use of AI. However, things could get more uncomfortable for pharmaceutical companies in the US market: the future US Secretary of Health and Human Services, Rober F. Kennedy Jr., is considered a critic of the industry and has already spoken out in favor of capping drug prices.
Article on tag "Novartis"
Gesundheit!
The desire for health is a constant companion in social life. In a developed country with a well-developed health and insurance system, it may be forgotten, but health is a highly unevenly distributed commodity.
IPOs in demand again
During the first quarter conditions for a stock market debut have improved. Recently big names have also increased expectations for further IPOs.
Possible breakthrough in gene technology driving biotechnology share prices
Biotech shares are regarded as highly promising due to the innovative strength of the sector, but they also tend to be subject to drastic price fluctuations both ways. After a long period of consolidation, biotech shares have embarked on a clear upward trend since May 2018. Harald Kober, Senior Fund Manager, explains the reasons for the investors’ optimism.